세계의 갱년기장애 치료 시장 : 치료 유형별, 투여 경로별, 제형별, 적응증별, 유통 채널별, 지역별
Global Menopause Treatment Market, By Treatment Type, By Route of Administration, By Form, By Indication, By Distribution Channel, By Geography
상품코드
:
1705790
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계 갱년기장애 치료 시장은 2025년에 152억 3,000만 달러로 추정되며, 2032년에는 230억 5,000만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 연평균 6.1%의 성장률을 보일 것으로 예상됩니다.
| 보고서 범위 |
보고서 상세 |
| 기준 연도 |
2024년 |
2025년 시장 규모 |
152억 3,000만 달러 |
| 실적 데이터 |
2020년부터 2024년까지 |
예측 기간 |
2025년부터 2032년까지 |
| 예측 기간 : 2025-2032년 CAGR |
6.10 |
2032년 가치 예측 |
230억 5,000만 달러 |
그림. 갱년기장애 치료 세계 시장 점유율(%), 지역별, 2025년
폐경은 보통 여성의 45세에서 55세 사이에 발생하는 자연적인 생물학적 과정입니다. 폐경은 여성의 생식기가 끝나고 생식 후의 삶으로 전환하는 것을 의미합니다. 폐경기의 가장 흔한 징후와 증상으로는 생리불순, 안면 홍조, 식은땀, 식은땀, 질 건조, 기분 변화, 수면 장애 등이 있습니다. 폐경기가 진행됨에 따라 여성의 에스트로겐 수치가 급격히 감소합니다. 따라서 이 과도기적 증상을 관리하는 것이 많은 여성들에게 우선순위가 되고 있습니다. 세계 갱년기장애 치료 시장은 갱년기 증상으로 고통받는 여성들에게 다양한 치료 옵션을 제공하고 있습니다.
시장 역학:
라이프스타일의 변화와 건강에 대한 인식이 높아지면서 여성들의 폐경기 유병률이 증가하고 있는 것이 세계 폐경기 치료제 시장의 성장을 촉진하는 주요 요인으로 작용하고 있습니다. 여러 조사에 따르면, 40-60세 여성의 약 4분의 1이 폐경과 관련된 문제 증상을 한 가지 이상 경험하고 있다고 보고하고 있습니다. 또한, 앉아서 일하는 직업과 운동 부족의 출현은 조기 폐경과 조기 폐경의 위험을 증가시킵니다. 또한, 주요 제약회사들의 신제품 승인과 출시로 갱년기 혈관운동증상을 치료할 수 있는 치료 옵션이 확대되고 있습니다. 그러나 호르몬 대체요법의 부작용과 대체 치료 옵션의 가용성은 여전히 시장 잠재력을 어느 정도 제한하고 있습니다. 또한, 개발도상국에서의 치료에 대한 인식 부족은 시장 관계자들에게 도전이 되고 있습니다. 그럼에도 불구하고, 갱년기장애 치료의 기술 발전과 아시아태평양의 의료 관광의 확대는 향후 몇 년 동안 이해관계자들에게 유리한 기회를 제공할 것으로 예상됩니다.
본 조사의 주요 특징
- 세계의 갱년기장애 치료 시장을 상세히 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 또한, 다양한 부문의 잠재적 수익 성장 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 갱년기장애 치료 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 갱년기장애 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 갱년기장애 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 신제품 발매
- 고령화 인구 증가
- 자금 원조와 투자에 의한 재정 지원
- 영향 분석
- 주요 하이라이트
- 시장 동향
- PEST 분석
- 규제 시나리오
- 합병, 인수 및 제휴
- 제공되는 주요 서비스
- 치료비 분석
- 상위 시장 기업 특정
- 정부 이니셔티브와 투자
- 브랜드 매핑과 가격 분석
- 국가별 헬스케어비 지출
제4장 세계의 갱년기장애 치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측 분석
- 경제에 대한 영향
제5장 세계의 갱년기장애 치료 시장, 치료 유형별, 2020-2032년
- 호르몬요법
- 에스트로겐계 약제
- 프로게스틴계 약제
- 배합약(에스트로겐과 프로게스틴, 에스트로겐과 기타 약제)
- 비호르몬요법
- 뉴로키닌 3(NK3)
- 수용체 길항제
- 선택적 세로토닌
- 재흡수 억제제(SSRI)
- 기타
- 기타
제6장 세계의 갱년기장애 치료 시장, 투여 경로별, 2020-2032년
제7장 세계의 갱년기장애 치료 시장, 제형별, 2020-2032년
제8장 세계의 갱년기장애 치료 시장, 적응증별, 2020-2032년
제9장 세계의 갱년기장애 치료 시장, 유통 채널별, 2020-2032년
- 병원 약국
- 소매 약국
- 온라인 약국
- 전문점
- 기타
제10장 세계의 갱년기장애 치료 시장, 지역별, 2020-2032년
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동
- 아프리카
제11장 경쟁 구도
- 기업 개요
- Novartis AG
- Pfizer Inc.
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Novo Nordisk A/S
- illendo Therapeutics, Inc.
- Mithra Pharmaceuticals
- Merck & Co., Inc
- Cipla Inc.
- Abbott
- Viatris Inc.
- Organon
- SnapNurse
- Glenmark Pharmaceuticals Limited
- Procter &Gamble
- Duchesnay USA.
- TherapeuticsMD, Inc.
- Avion Pharmaceuticals
- KWS
- PharmaCare Europe Ltd.
- Amneal Pharmaceuticals LLC.
제12장 섹션
ksm
영문 목차
Global Menopause Treatment Market is estimated to be valued at USD 15.23 Bn in 2025 and is expected to reach USD 23.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 15.23 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
6.10% |
2032 Value Projection: |
USD 23.05 Bn |
Figure. Global Menopause Treatment Market Share (%), By Region 2025
Menopause is a natural biological process that usually occurs between the ages of 45 to 55 years in women. It marks the end of a woman's reproductive years and the transition into her post-reproductive life. Some of the most common signs and symptoms of menopause include irregular menstrual periods, hot flashes, night sweats, vaginal dryness, mood changes, and difficulty sleeping. As menopause progresses, a woman's estrogen levels drop dramatically, which could lead to several long-term health risks if left untreated. Therefore, managing symptoms during this transitional phase has become a priority for many women. The global menopause treatment market offers a variety of treatment options for women suffering from menopause symptoms.
Market Dynamics:
The rising prevalence of menopause issues among women owing to changing lifestyle patterns and growing health awareness levels is a key factor driving the growth of global menopause treatment market. Numerous researches have shown that approximately one-fourth of women within the age group of 40 to 60 years report experiencing at least one problematic symptom associated with menopause. There is also the emergence of sedentary jobs and a lack of physical activity, which has escalated the risks of premature or early menopause. Additionally, new product approvals and launches by leading pharmaceutical players are expanding the treatment choices for addressing vasomotor symptoms during menopause. However, side effects associated with hormone replacement therapy and the availability of alternative treatment options still limit the market potential to a certain extent. Moreover, a lack of awareness about treatment in developing nations poses a challenge to market players. Nonetheless, technological advancements in menopausal care and growing medical tourism in the Asia Pacific region are expected to unlock lucrative opportunities for stakeholders in coming years.
Key Features of the Study:
- This report provides an in-depth analysis of the global menopause treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global menopause treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Novartis AG, Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Novo Nordisk A/S, illendo Therapeutics, Inc., Mithra Pharmaceuticals, Merck & Co., Inc, Cipla Inc., Abbott, Viatris Inc., Organon, SnapNurse, Glenmark Pharmaceuticals Limited, Procter & Gamble, Duchesnay USA., TherapeuticsMD, Inc., Avion Pharmaceuticals, KWS, PharmaCare Europe Ltd., Amneal Pharmaceuticals LLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global menopause treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menopause treatment market
Detailed Segmentation:
- Global Menopause Treatment Market, By Treatment Type
- Hormone Therapy
- Estrogen-based Drugs
- Progestin-based Drugs
- Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
- Non-hormonal Therapy
- Neurokinin 3 (NK3)
- Receptor Antagonist
- Selective Serotonin
- Reuptake Inhibitor (SSRI)
- Others
- Others
- Global Menopause Treatment Market, By Route of Administration
- Oral
- Topical
- Parenteral
- Vaginal
- Others
- Global Menopause Treatment Market, By Form
- Tablets
- Creams
- Patches
- Pessaries
- Injections
- Others
- Global Menopause Treatment Market, By Indication
- Perimenopause
- Menopause
- Postmenopause
- Global Menopause Treatment Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Specialty Stores
- Others
- Global Menopause Treatment Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles
- Novartis AG
- Pfizer Inc.
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Novo Nordisk A/S
- illendo Therapeutics, Inc.
- Mithra Pharmaceuticals
- Merck & Co., Inc
- Cipla Inc.
- Abbott
- Viatris Inc.
- Organon
- Glenmark Pharmaceuticals Limited
- Procter & Gamble
- Duchesnay USA.
- TherapeuticsMD, Inc.
- Avion Pharmaceuticals
- KWS
- PharmaCare Europe Ltd.
- Amneal Pharmaceuticals LLC.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Treatment Type
- Market Snippet, By Route of Administration
- Market Snippet, By Form
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- New Product Launches
- Rising Geriatric Population
- Financial Support Through Funding And Investments
- Impact Analysis
- Key Highlights
- Market Trends
- PEST Analysis
- Regulatory Scenario
- Mergers, Acquisitions, and Collaborations
- Key Services Offered
- Treatment cost Analysis
- Identification of Top Market Players
- Government Initiatives and Investments
- Brand Mapping & Pricing Analysis
- Healthcare Spending by Country
4. Global Menopause Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Menopause Treatment Market, By Treatment Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hormone Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Estrogen-based Drugs
- Progestin-based Drugs
- Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
- Non-hormonal Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Neurokinin 3 (NK3)
- Receptor Antagonist
- Selective Serotonin
- Reuptake Inhibitor (SSRI)
- Others
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global Menopause Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Vaginal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Menopause Treatment Market, By Form, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Pessaries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Global Menopause Treatment Market, By Indication, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Perimenopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Menopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Postmenopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Global Menopause Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Specialty Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
10. Global Menopause Treatment Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region/Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region/Country, 2021 - 2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Company Profile
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Novo Nordisk A/S
- illendo Therapeutics, Inc.
- Mithra Pharmaceuticals
- Merck & Co., Inc
- Cipla Inc.
- Abbott
- Viatris Inc.
- Organon
- SnapNurse
- Glenmark Pharmaceuticals Limited
- Procter & Gamble
- Duchesnay USA.
- TherapeuticsMD, Inc.
- Avion Pharmaceuticals
- KWS
- PharmaCare Europe Ltd.
- Amneal Pharmaceuticals LLC.
- Analyst Views
12. Section
- References
- Research Methodology
- About us
관련자료
